Napafen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Napafen

Quick Facts

  • Primary Active Ingredient: Acetaminophen (also known as Paracetamol)
  • Drug Class: Analgesic (pain reliever) and Antipyretic (fever reducer)
  • Available Forms: Varies by product, typically oral tablets, capsules, or suspensions.

Napafen is a pharmaceutical product whose primary active ingredient is acetaminophen (also called paracetamol). This substance is one of the most widely used over-the-counter (OTC) medications globally and is classified as an analgesic and antipyretic. While it is highly effective in reducing fever and relieving mild-to-moderate pain, it exhibits very weak anti-inflammatory properties, distinguishing it from nonsteroidal anti-inflammatory drugs (NSAIDs).

Acetaminophen works by inhibiting certain pathways in the body that produce substances responsible for signaling pain and raising the body's temperature, thus providing relief for various conditions. Napafen is used for the temporary relief of minor aches and pains, such as those caused by headache, muscular aches, minor arthritis pain, the common cold, and toothache, and for the reduction of fever. Like many brand-name medications, Napafen may be formulated as a single-ingredient product or as a combination product containing acetaminophen along with other active ingredients to address symptoms like cough or congestion, which is why reading the product label carefully before use is essential.

What side effects are possible with Napafen?

Possible Side Effects and Safety Information

The safety profile of Napafen, whose active ingredient is acetaminophen (paracetamol), is formally defined by official regulatory documentation, which classifies potential adverse reactions by frequency and physiological system.


Adverse Reaction Scope

Classification Organ System Categories
Very Rare (incidence < 1/10,000) Hepatobiliary, Blood and Lymphatic, Skin and Subcutaneous Tissue, Immune System
Rare (incidence > 1/10,000 - < 1/1,000) Gastrointestinal, Renal and Urinary, Nervous System

Serious adverse reactions, though classified as Very Rare, are explicitly highlighted in regulatory texts. These include Acute Liver Failure or Hepatic Necrosis, which is the most critical safety concern often associated with high doses. Other serious documented reactions are Severe Skin Reactions (such as Stevens-Johnson Syndrome) and Anaphylactic Reactions.


Official Safety Constraints

Safety notes in the official labeling specify particular considerations for certain populations and usage patterns:

  • Population-Specific: Increased risk of adverse events is documented for individuals with pre-existing hepatic impairment (liver disease), severe renal impairment, or those who engage in chronic alcohol consumption.
  • Exposure-Related: The risk of renal adverse events and medication-overuse headache is associated with long-term, frequent use. The label explicitly restricts the concomitant use of other acetaminophen-containing products due to the severe risk of liver damage.

The regulatory structure ensures that potential risks are clearly communicated based on standardized reporting data.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information for Napafen

Immediate medical attention must be sought in the event of any suspected overdose of Napafen, even if the individual feels well or appears asymptomatic. Urgent referral to a hospital is mandated by regulatory authorities due to the significant risk of delayed, severe liver damage.

Documented manifestations in the initial phase (up to 24 hours) may include non-specific symptoms such as nausea, vomiting, diaphoresis, pallor, and general malaise. The toxicity is primarily focused on the hepatic system, leading to the most serious consequence officially listed: Fatal Hepatic Necrosis and progression to acute liver failure. Late-stage signs include jaundice and laboratory abnormalities such as elevated hepatic transaminases and abnormal Prothrombin Time (INR).

The primary management for a potentially toxic dose involves administering the specific antidote, N-acetylcysteine (NAC). This treatment is time-critical; its effectiveness diminishes significantly if administration is delayed beyond 8 hours post-ingestion. Monitoring of plasma acetaminophen concentration and continuous hospital observation are required to assess toxicity and guide treatment.

The regulatory profile notes that individuals with non-cirrhotic alcoholic liver disease or who are chronic heavy alcohol users face a greater hazard of severe complications following an overdose. The necessity for time-sensitive intervention defines the regulatory approach to Napafen overdose.

Therapeutic Uses of Napafen

What Napafen Treats: Main Uses and Benefits

Napafen's utility is focused on symptomatic relief across two major clinical domains and is considered relevant for supporting patients managing acute and episodic discomfort. It is classified as an analgesic and antipyretic.

Napafen is commonly used across conditions presenting with systemic or localized discomfort, including headaches, muscular aches, minor pain of osteoarthritis, backache, toothaches, and discomfort associated with the menstrual cycle. It is applied in clinical settings that involve acute or unstable symptom patterns such as elevated body temperature due to seasonal illnesses like the common cold and flu, or following vaccination reactions.

When these symptoms interfere with daily functioning, Napafen contributes to improved comfort during periods of heightened symptoms. This provides supportive relief when symptoms temporarily escalate, helping patients cope more steadily.


Quick Fact: Therapeutic Scope for Fever and Minor Discomfort

Napafen is commonly used to help with groups of symptoms that may appear suddenly or fluctuate, and is applied to help with managing fever and easing minor to moderate pain.

Regulatory References

  1. National Library of Medicine's MedlinePlus overview of Acetaminophen

Eligibility and Restrictions for Use

The eligibility for Napafen (Naproxen) is strictly defined by regulatory guidelines, focusing on absolute contraindications and conditions requiring limited use.

Contraindicated Populations

Category Regulatory Status
Hypersensitivity Absolutely Contraindicated in patients with known allergy to naproxen, aspirin, or other NSAIDs (history of asthma, urticaria, or allergic-type reactions).
Heart Surgery Contraindicated for treating peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Late Pregnancy Contraindicated starting at 30 weeks gestation (third trimester) due to risk of fetal cardiovascular harm.

Restricted Use and Special Caution

Use is generally not recommended or requires strict medical oversight in patients with certain conditions:

  • Severe Organ Impairment: Avoid or use with extreme caution in severe heart failure, severe hepatic failure, or advanced renal disease (CrCl < 30 mL/min).
  • Gastrointestinal Risk: Contraindicated with active gastrointestinal bleeding or a history of recurrent peptic ulceration/hemorrhage.
  • Age Groups: Safety and efficacy are generally not established for most indications in children under 16 years. Older adults must be treated cautiously with the lowest effective dose due to increased risk of adverse events.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Napafen, which contains acetaminophen (paracetamol), is defined by official regulatory documents to manage pharmacokinetic changes and specific pharmacodynamic risks. A core constraint is the contraindication of co-administration with any other medicinal product containing acetaminophen (prescription or over-the-counter), a restriction designed to prevent accidental overdose and severe liver damage.

Officially documented pharmacokinetic interactions occur with substances that affect the clearance of Napafen's active ingredient. Probenecid is documented to increase plasma concentration by inhibiting clearance. Conversely, Cholestyramine reduces absorption and requires a mandatory timing separation, with Napafen administered at least one hour before or four hours after Cholestyramine. Co-administration with certain hepatic enzyme-inducing medicines (e.g., Phenytoin, Rifampicine) and chronic alcohol consumption is officially associated with an increased risk of hepatotoxicity through enhanced formation of a toxic metabolite.

Pharmacodynamic interactions are documented with Vitamin K antagonists (e.g., Warfarin), where co-administration can enhance the anticoagulant effect, increasing the risk of bleeding. Certain antibiotics, such as Flucloxacillin, are noted in official labeling for a risk of high anion gap metabolic acidosis.

Mechanism of Action

The drug's mechanism of action involves distinct pathways primarily located within the Central Nervous System (CNS). One key mechanistic domain is the central inhibition of prostaglandin synthesis. This occurs through interference with cyclooxygenase (COX) activity, likely targeting a central COX isoenzyme. This targeted modulation is biochemically significant as it directly influences the hypothalamic signaling that regulates the body's thermostatic set point.

Another major domain involves the modulation of descending pain pathways. Following administration, an active metabolite, AM404, is formed within the CNS. This metabolite interacts with and modulates systems such as the TRPV1 receptor and potentially the Cannabinoid 1 (CB1) receptor in the brain and spinal cord. Engaging these pathways supports the descending inhibitory system, a distinct, non-COX-dependent cascade that influences the regulation of nociceptive signal transmission.

Dosage and Administration Information

The official administration of Napafen (acetaminophen/paracetamol) is governed by strict regulatory rules defining the dose, frequency, and maximum permitted intake. This medication is authorized for use via Oral, Intravenous (IV), and Rectal routes, depending on the patient setting and necessity, as outlined in official prescribing information.


Official Dosing and Frequency

For adults weighing 50 kg or more, the standard immediate-release oral dose ranges from 325 mg up to a maximum of 1000 mg per single administration. Doses must be separated by a minimum interval of 4 hours for immediate-release forms and 8 hours for extended-release forms. A crucial limit established by regulatory agencies is the Maximum Daily Dose of 4000 mg (4 grams) from all acetaminophen-containing sources in a 24-hour period.


Special Administration Rules

Usage rules are adjusted for specific populations: Dosing for children or patients weighing less than 50 kg is calculated based on body weight (10-15 mg/kg per dose), not fixed adult amounts. Furthermore, for patients with impaired kidney function, the official instruction is to extend the minimum interval between doses to prevent accumulation. Oral Napafen may be taken with or without food. Extended-release tablets must be swallowed whole to maintain their intended time-release characteristics and must not be crushed or chewed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Napafen

Napafen's active ingredient, acetaminophen, was studied in research exploring short-term or episodic symptom patterns across several conditions. Research helps contextualize how patients reported their experience and provides insight into short-term changes.


Evidence for Use in Acute Pain and Discomfort

Research exploring short-term symptom changes associated with physical discomfort is largely based on Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies focused on patient-reported outcomes describing perceived discomfort and the recorded use of supplemental pain relief. Study populations included adults, adolescents, and children presenting with acute discomfort, such as following dental procedures or minor surgeries.

Findings describe patterns observed in the studies related to measured changes in perceived discomfort within the first few hours or up to a full day following administration. The full pattern of response across pain types over periods longer than 24 hours is not well characterized, as follow-up durations were limited in many definitive acute pain trials.


Evidence for Use in Fever Reduction (Antipyresis)

Napafen was evaluated in numerous clinical trials and systematic reviews examining temporary physiological imbalance. These studies focused on outcomes related to systemic imbalance, specifically monitoring body temperature measurements in populations of adults and children presenting with elevated body temperature.

Studies monitored temperature over defined time intervals, describing patterns that were observed. Existing studies provide limited insight into the sustained observation of temperature changes beyond the 6-hour post-dose period. Data for certain groups remain insufficient regarding differences in observed outcomes based on the specific cause of the elevated temperature.


Research Evidence for Minor Chronic Pain

Research exploring chronic, ongoing discomfort primarily includes RCTs and meta-analyses focused on adults with minor pain associated with osteoarthritis. Studies monitoring chronic pain patterns reported a range of observed changes in functional measurements, and research highlights that findings were mixed across these studies. Evidence remains limited for the continuous, long-term use in chronic conditions, as the follow-up durations were limited (often leq 3 months) for a chronic condition.

Key Studies & References National Library of Medicine (NLM) MedlinePlus Overview of Acetaminophen

Frequently Asked Questions (FAQ)

Common questions about Napafen (FAQ)


Q: Is Napafen the same as other medicines for this condition?

Napafen's active ingredient is classified as an analgesic (pain reliever) and an antipyretic (fever reducer). Official sources indicate it has very weak anti-inflammatory effects, which is a key difference that distinguishes it from nonsteroidal anti-inflammatory drugs (NSAIDs) used for similar symptoms.


Q: How long after stopping Napafen does it stay in my system?

According to pharmacokinetic data found in official documents, the amount of the medication in the bloodstream reduces by half every 2 to 3 hours in healthy adults (this is known as the half-life). For most patients, the majority of the substance is typically eliminated from the body through urine within about 24 hours after the last dose.


Q: Does Napafen cause drowsiness or tiredness?

Official product information lists fatigue and unusual tiredness or weakness among the side effects that have been reported by users. The frequency of these reactions can vary depending on the specific form of the medicine used.


Q: Can Napafen affect my ability to drive or operate machinery?

Reported side effects involving the Nervous System, such as dizziness and headache, are noted in regulatory documents. These types of effects may potentially impact the ability to perform tasks that require complete mental alertness, such as driving or operating machinery.


Q: Does Napafen affect blood pressure or blood sugar levels?

Official product labeling does not cite effects on blood pressure or blood sugar levels as primary known effects for the general population. However, some specialized studies concerning patients with pre-existing conditions have shown associations between daily use and potential changes in blood pressure or effects on how the body processes sugar. Individual use must be discussed with a healthcare provider.


Q: What happens if I stop taking Napafen suddenly?

Official warnings state that long-term or frequent use of Napafen is associated with the risk of developing medication-overuse headache. If the medicine is discontinued, this condition may be observed or altered.


Q: Can I take other pain relievers while using Napafen?

The most crucial constraint in official regulatory labeling is that co-administration with any other medicine that contains acetaminophen (paracetamol) is officially not recommended due to the risk of accidental overdose and severe liver damage. The product information describes various potential interactions but does not provide generalized guidance on combining with all non-acetaminophen pain relievers.


Q: Can taking Napafen affect mood or mental clarity?

Official product information lists adverse reactions within the Psychiatric system, including insomnia (difficulty sleeping) and anxiety. These documented effects are associated with changes in mental state or mood.


Q: How quickly does Napafen usually start working?

According to pharmacokinetic data, the medicine is rapidly absorbed after ingestion. The concentration of the medicine in the blood typically reaches its peak within 30 minutes to 2 hours following an oral dose.


Q: How long do the effects of Napafen last?

The effect of Napafen is generally described in relation to its dosing schedule. For the immediate-release form, the administration interval is typically recommended every 4 to 6 hours as needed, which is an indication of the expected duration of the effects.


Q: Can Napafen be taken by older adults (e.g., people over 65)?

Official guidance states that appropriate studies have generally not demonstrated geriatric-specific problems that would limit its usefulness. However, use is often advised with caution, and a lower maximum daily dose is sometimes advised by a healthcare provider.


Q: Is it normal to feel a mild stomach upset when starting Napafen?

Official documents list nausea and vomiting among the commonly reported side effects. These effects may be observed, particularly when the medicine is first started or depending on the form of administration.


Q: Does Napafen interact with common vitamins or supplements?

While no absolute contraindication is documented for general multivitamins or minerals, patients are officially advised to inform their healthcare professional about all supplements and herbs they are taking. This general precaution is in place to allow for full consideration of potential interaction risks.


Q: Can I drink coffee or tea while taking Napafen?

Napafen's active ingredient is combined with caffeine in some approved products, which suggests general compatibility. However, consuming the medicine alongside very high doses of caffeine can increase the risk of side effects like nervousness or restlessness.


Q: What should I do if I miss a scheduled dose of Napafen?

Official instructions state that if you are taking the medicine on a regular schedule, you may take the missed dose as soon as you remember. If it is almost time for the next dose, official instructions suggest skipping the missed dose and not taking extra medicine to compensate.


Q: Are there any long-term effects of taking Napafen for many months?

Official warnings state that long-term, frequent use is associated with potential risks. These include the documented increased risk of renal adverse events (kidney-related issues) and the development of medication-overuse headache.


Q: Is Napafen safe to use if I have kidney issues?

Official regulatory documents indicate that patients with severe renal impairment (severe kidney issues) have a documented increased risk of adverse events. For these patients, official instructions suggest that the minimum interval between doses may need to be extended to reduce the chance of accumulation.


Q: Can people with liver problems use Napafen?

The product is contraindicated (not to be used) in patients with severe hepatic impairment or active liver disease. This requirement is based on the increased risk of toxicity for individuals with liver conditions.


Q: Is Napafen safe for teenagers or children?

Appropriate studies have generally not shown specific problems that would limit its usefulness for teenagers and children. Official instructions require that dosing for children be calculated precisely based on body weight, and over-the-counter use for children under 2 years requires the guidance of a healthcare provider.


Q: Do I need to change my diet while using Napafen?

The oral form of the medication may generally be taken with or without food. However, some formulations contain ingredients like aspartame (a source of phenylalanine), which requires specific caution for individuals with the inherited disorder Phenylketonuria (PKU).


Q: Can I take Napafen if I have a history of heart conditions?

Official regulatory labeling for Napafen (Acetaminophen) does not include a cardiovascular risk warning, unlike some other classes of pain relievers. The active ingredient is often identified as an appropriate option for pain relief in patients with heart conditions, but individual use requires professional oversight.


Q: What kind of research has been done on Napafen?

Official documents and medical reviews show that research exploring the drug's effects is largely based on Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies primarily focus on providing evidence for short-term symptom relief in cases of acute pain and fever reduction.


Q: Is Napafen a commonly prescribed medicine?

Napafen's active ingredient is one of the most widely used over-the-counter (OTC) medicines globally. However, it is also an ingredient in various prescription-only combination products.


Q: Are there any specific foods I should avoid when taking Napafen?

Official product information states that the medicine can generally be taken with or without food. While specific food-drug interactions are generally not highlighted in patient labeling, minor effects from specific foods, such as certain cruciferous vegetables, have been noted in research literature.


Q: What do studies say about Napafen use while breastfeeding?

Regulatory databases and studies indicate that the amount of the drug transferred into breast milk is significantly less than the dose typically given directly to infants. Official information generally considers the medicine acceptable for use for nursing mothers seeking pain relief or fever reduction.


Q: Can Napafen make certain existing health problems worse?

Yes, official labeling specifies that certain pre-existing conditions are associated with an increased risk of adverse events or toxicity. These include liver disease, severe kidney disease, severe heart failure, and chronic alcohol consumption.


Q: Why is Napafen sometimes used for different conditions?

The medicine is officially classified as an analgesic (pain reliever) and an antipyretic (fever reducer). These two primary functions allow it to provide temporary relief for the symptoms common to a wide variety of conditions, such as headaches, muscular aches, and fever.


Q: What is the evidence level (e.g., Phase 3 trials) for Napafen?)

The evidence supporting the use and approval of the drug is based on robust efficacy data. This includes numerous Randomized Controlled Trials (RCTs) and Systematic Reviews that fulfill the requirements for clinical evidence similar to modern Phase 3 trials.


Q: Do people typically take Napafen short-term or long-term?

Official labeling describes the medicine's primary use as the temporary relief of minor aches and pains. Official guidance cautions against continuous use for longer than two weeks without medical consultation due to the documented risks of long-term adverse events, such as kidney and liver issues.


Q: Is Napafen available over the counter, or only by prescription?

The active ingredient is available in many forms as an Over-the-Counter (OTC) product that can be purchased without a prescription. However, it is also an ingredient in various prescription-only combination products.


Q: Do clinical trials for Napafen include diverse patient groups?

Studies used in the evaluation of Napafen include a breadth of patient populations, such as adults, adolescents, and children presenting with acute pain and fever.


Q: Is Napafen safe for use if I have severe allergies?

Official warnings instruct that the user must stop taking the medicine immediately and seek emergency medical attention if symptoms of a severe allergic reaction occur. These symptoms include hives, swelling of the face, throat, or lips, or difficulty breathing.


Q: What is the difference between the immediate-release and extended-release versions of Napafen?

The key difference is the expected duration of effect. The immediate-release form is generally taken every 4 to 6 hours, whereas the extended-release version is formulated to deliver relief over a longer period, typically with a regulated dosing interval of 8 hours.

How should Napafen be stored and disposed of?

How to Store and Dispose of Napafen

Official regulatory guidelines define specific requirements for storing and disposing of Napafen (Acetaminophen/Paracetamol) to maintain its stability and ensure safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Avoid excessive heat and freezing.
Protection Keep the medicine in its original, tightly closed container. Protect from moisture and light.
Safety Always keep Napafen out of the reach of children and pets. Do not use the product past its expiration date.

Disposal Instructions

Unused or expired Napafen should ideally be disposed of via a drug take-back program or a community collection point. If these options are unavailable, the medicine must be discarded in the household trash. This involves mixing the drug with an unappealing substance, such as dirt or used coffee grounds, and sealing the mixture in a container before disposal. Do not flush Napafen down the toilet unless specifically authorized by the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Napafen found in:

A-Z Index: